Astrana Health (ASTH) Cost of Revenue (2010 - 2026)

Astrana Health has disclosed Cost of Revenue across 17 years of filings, most recently posting $859.4 million for Q1 2026.

• Cost of Revenue for Q1 2026 came in at $859.4 million, up 56.51% year-over-year; the trailing twelve-month figure through Mar 2026 was $3.2 billion (up 58.97% YoY), and the FY2025 annual result was $2.8 billion, up 61.09% from the prior year.
• Cost of Revenue came in at $859.4 million for Q1 2026 at Astrana Health, roughly flat from $855.5 million in the prior quarter.
• In the past five years, Cost of Revenue ranged from a high of $859.4 million in Q1 2026 to a low of $220.7 million in Q1 2022.
• The 5-year median for Cost of Revenue is $330.4 million (2024), against an average of $445.8 million.
• Across the five-year window, Cost of Revenue rose 14.17% in 2024 and jumped 111.95% in 2025, its largest moves.
• Astrana Health's Cost of Revenue stood at $253.1 million in 2022, then grew by 24.07% to $314.1 million in 2023, then surged by 95.74% to $614.7 million in 2024, then soared by 39.16% to $855.5 million in 2025, then advanced by 0.45% to $859.4 million in 2026.
• The last three Cost of Revenue figures came in at $859.4 million (Q1 2026), $855.5 million (Q4 2025), and $858.9 million (Q3 2025), per Business Quant data.